February 28th, 2017

Keynote Presentation:

Schahram Akbarian, M.D., Ph.D.

Chief, Division of Epigenomics at Icahn School of Medicine at Mount Sinai

“The Human Brain And Its Epigenome”

Corporate Presenters:

Robert Rollins, Ph.D.

Pfizer Research & Development

Senior Principal Scientist, Oncology Therapeutics Discovery – Epigenetics

“Epigenetic Cancer Therapy: Promises and Challenges”

Krishnan Viswanadhan, Pharm.D., MBA

Celgene Corporation – Strategic Development Leader

“Development of IDH2 Inhibitor, Enasidenib in AML”